Search the Newsreel

Earnings Flash (XRAY) DENTSPLY SIRONA Inc. Posts Q2 Adjusted EPS $0.52 per Share

DENTSPLY SIRONA Inc. (XRAY) announced its Q2 adjusted EPS of $0.52 per share. This earnings flash follows a previous report that the company's Q2 revenue was $898.0M, exceeding FactSet estimates of $889.9M. The company is a diversified manufacturer of professional dental products and technologies.

BRIEF-Dentsply Sirona Q2 Revenue USD 898 Million Vs. IBES Estimate USD 889.8 Million

Dentsply Sirona announced its Q2 revenue reached USD 898 million, surpassing the IBES estimate of USD 889.8 million. This brief report highlights the company's financial performance relative to analyst expectations.

DENTSPLY SIRONA Inc. legt Ergebnisse für das zweite Quartal und das erste Halbjahr bis zum 30. Juni 2026 vor

DENTSPLY SIRONA Inc. bekräftigt Gewinnprognose für das Jahr 2026

Dentsply Sirona investors brace for earnings amid Medline threat By Investing.com

Dentsply Sirona Inc. is preparing to report second-quarter earnings, facing investor scrutiny over its ability to counter competitive pressure from Medline's expansion into the dental market. Analysts forecast earnings of 35 cents per share and revenue of $889.2 million, representing a significant year-over-year decline. …

Arkadios Wealth Advisors Purchases New Stake in DENTSPLY SIRONA Inc. $XRAY

Arkadios Wealth Advisors recently acquired a new stake of 74,961 shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY), valued at approximately $870,000. Despite this new investment and insider purchases totaling over $200,000 in June, analyst sentiment remains cautious, with an average "Hold" rating and a target …

Expanded Medline Sinclair Tech Distribution in Canada Could Be A Game Changer For DENTSPLY SIRONA (XRAY)

DENTSPLY SIRONA recently announced an expanded partnership with Medline Sinclair for full technology portfolio distribution in Canada, effective September 1, 2026. This move could significantly scale DENTSPLY SIRONA's digital dentistry solutions in the Canadian market. The announcement comes ahead of the Q2 2026 earnings …

[10-Q] DENTSPLY SIRONA Inc. Quarterly Earnings Report

Earnings To Watch: Dentsply Sirona (XRAY) Reports Q2 Results Tomorrow

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

DENTSPLY SIRONA (XRAY) is scheduled to release its second-quarter 2026 results, with analysts expecting revenues of $883.9 million and earnings of 36 cents per share. The company's "Return-to-Growth" action plan and ongoing investments are key factors, alongside challenges from dealer inventory adjustments, tariffs, and …

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA

Faruqi & Faruqi, LLP is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ: XRAY) on behalf of investors who suffered losses exceeding $75,000 between February 28, 2022, and November 6, 2024. The investigation stems from allegations that Dentsply made misleading statements and failed to …

Dentsply Sirona’s Endo Forum 2026 explores advances in endodontic care

Dentsply Sirona's Endo Forum 2026 brought together over 80 endodontic experts in Spain to discuss advancements, emerging trends, and future innovations in endodontic care. The event facilitated dialogue between clinicians and Dentsply Sirona's product development teams, leading to discussions on digital workflows, new products …

DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Quantinno Capital Management LP

Can Dentsply Sirona (XRAY) Turn Its Business Around?

Ariel Investments, an investment management company, released its "Ariel Focus Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund returned 2.14% in the second quarter of 2026, underperforming the Russell 1000 Value and S&P 500, which gained …

Price to book forward of DENTSPLY SIRONA, Inc. – BX:DY2

This article provides financial data for DENTSPLY SIRONA, Inc. (BX:DY2), specifically its price-to-book forward ratio. It indicates that the market is closed for this stock and no trades have occurred. The content is primarily a data point with no further analysis or discussion.

DENTSPLY SIRONA Inc (XRAY) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of DENTSPLY SIRONA Inc (XRAY), noting its current financial score is 6.13, ranking it 172 out of 199 in the Healthcare Equipment & Supplies industry. Despite a weak overall financial status, the company shows high operating efficiency. …

Dentsply Sirona Number of Employees 2026 | Employee Count & Headcount Data

Dentsply Sirona (NASDAQ: XRAY) had approximately 13,897 employees worldwide as of March 2026, representing a 4.7% decline since 2023. The company is actively hiring with 802 job postings in 2026, though new postings per month have decreased. The workforce is concentrated in North America, …

DENTSPLY SIRONA (XRAY) Expected to Release Earnings on Thursday

DENTSPLY SIRONA (NASDAQ:XRAY) is scheduled to release its Q2 2026 earnings after market close on Thursday, August 6th. Analysts are anticipating earnings of $0.36 per share and revenue of $889.2140 million. The company previously reported Q1 2026 EPS of $0.27, missing estimates, but exceeding …

DENTSPLY SIRONA Inc (XRAY) Q1 2026 Earnings Report - Results, Call & Slides

DENTSPLY SIRONA (XRAY) reported its Q1 2026 earnings, missing EPS estimates at $4.71 against a consensus of $4.85, but beating revenue expectations with $15.36 billion. The company maintained its full-year 2026 guidance, citing improved operating cash flow, debt reduction, early cost savings from restructuring, …

Dentsply Sirona Is Maintained at Neutral by Piper Sandler

Piper Sandler has reiterated its "Neutral" rating for Dentsply Sirona. This indicates the firm's ongoing assessment that the stock is expected to perform in line with the market.

XRAY Maintained by Piper Sandler -- Price Target Raised to $14.0

Piper Sandler has maintained a Neutral rating for Dentsply Sirona (XRAY) and raised its price target from $13.00 to $14.00, signaling cautious optimism for the company's future. Despite current unprofitability, XRAY is considered 26.3% undervalued according to its GF Value™ of $18.99, and insider …

Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Halper Sadeh LLC, an investor rights law firm, is investigating whether officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders. The firm encourages long-term shareholders to contact them to discuss legal options, including seeking corporate governance reforms or …

DENTSPLY SIRONA Inc (XRAY) Institutional Confidence

DENTSPLY SIRONA Inc's institutional confidence score is 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding decreased by 9.16% quarter-over-quarter to 111.69%, with First Eagle Investment being the largest shareholder. The article lists top institutional shareholders and their recent share …

Southpoint Capital Advisors LP Buys Shares of 10,000,000 DENTSPLY SIRONA Inc. $XRAY

Southpoint Capital Advisors LP acquired a new stake of 10 million shares in DENTSPLY SIRONA Inc. (XRAY) during the first quarter, valued at approximately $116 million. This purchase represents 4.99% of DENTSPLY SIRONA and 2.4% of Southpoint Capital's portfolio. Institutional ownership of DENTSPLY SIRONA …

DENTSPLY SIRONA, Inc. Revenue Breakdown – HAM:DY2

DENTSPLY SIRONA, Inc. (HAM:DY2) reported a total revenue of 3.13 billion EUR last year. The Essential Dental Solutions segment was the top performer, generating 1.25 billion EUR. The United States was the largest regional contributor, accounting for 1.01 billion EUR of the revenue.

Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors. Effective September 1, 2026, Medline …

Dental distributor Medline Sinclair will offer Dentsply Sirona tech Sept. 1

Dentsply Sirona announced an expanded partnership with Medline Sinclair, a leading Canadian dental distributor, to offer its technology portfolio across Canada starting September 1, 2026. This move is Dentsply Sirona's sixth dealer network enhancement in 2026, aiming to broaden access to digital dentistry solutions. …

Lazard Asset Management LLC Has $77.90 Million Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Lazard Asset Management LLC significantly reduced its stake in DENTSPLY SIRONA Inc. by 23.1% in the first quarter, selling over 2 million shares but still retaining holdings valued at $77.9 million. Despite this, other institutional investors have increased their positions, with institutions collectively owning …

DENTSPLY SIRONA Inc (XRAY) Cash Flow

This article from Tradingkey.com provides a detailed cash flow statement for DENTSPLY SIRONA Inc (XRAY), including annual and quarterly data for operating, investing, and financing activities. It breaks down various cash flow components such as net income, capital expenditures, debt issuance/repayment, and dividend payments. …

DENTSPLY SIRONA Inc (XRAY) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of DENTSPLY SIRONA Inc (XRAY), including major institutional holders and their proportions. It lists top shareholders like BlackRock and First Eagle Investment Management, along with a breakdown of shareholder types such as investment advisors and hedge funds. The …

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DENTSPLY SIRONA

Faruqi & Faruqi, LLP is investigating potential claims against DENTSPLY SIRONA Inc. (NASDAQ: XRAY) on behalf of investors who suffered losses exceeding $75,000 between February 28, 2022, and November 6, 2024. The firm alleges that Dentsply made false or misleading statements regarding its Byte …

Morgan Stanley Maintains Dentsply Sirona(XRAY.US) With Hold Rating

Morgan Stanley has reiterated its Hold rating on Dentsply Sirona (XRAY.US). The firm also maintained its price target for the company.

3 Reasons to Sell XRAY and 1 Stock to Buy Instead

This article recommends selling Dentsply Sirona (XRAY) due to declining constant currency revenue, decreasing earnings per share, and negative return on invested capital. The company's recent stock performance has lagged the market, and despite an "optically cheap" valuation, its fundamental issues suggest significant downside. …

Dentsply Sirona to Host Second Quarter Conference Call on August 6th

Dentsply Sirona announced that it will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to discuss its second-quarter 2026 financial results. Financial earnings materials will be available on the Investors section of the Company's website …

Dentsply Sirona to review Q2 2026 results on August 6

Dentsply Sirona announced it will host an investor conference call and live webcast on August 6, 2026, at 4:30 p.m. ET, to discuss its second-quarter 2026 financial results. Financial earnings materials will be posted on the company's investor website prior to the call. A …

DENTSPLY SIRONA Inc. (XRAY) discloses initial insider filing for CFO

DENTSPLY SIRONA Inc. (XRAY) has filed an initial insider ownership report (Form 3) for its new Executive Vice President and Chief Financial Officer, John C. Fortson. The filing identifies Fortson as a reporting insider but shows no equity transactions or holdings. It also notes …